Olfactory function in mild cognitive impairment and Alzheimer's disease: An investigation using psychophysical and electrophysiological techniques

American Journal of Psychiatry

Volumn 160, Issue 11, 2003, Pages 1995-2002

  Peters, Jürgen M ^a   Hummel, Thomas ^a   Kratzsch, Tilman ^a   Lötsch, Jörn ^a   Skarke, Carsten ^a   Frölich, Lutz ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; HUMAN; LATENT PERIOD; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHYSIOLOGY; SMELLING;

AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CARBON DIOXIDE; COGNITION DISORDERS; ELECTROPHYSIOLOGY; EVOKED POTENTIALS; FEMALE; HUMANS; HYDROGEN SULFIDE; MALE; MIDDLE AGED; OLFACTION DISORDERS; OLFACTORY PATHWAYS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPHYSICS; SENSORY THRESHOLDS; SEVERITY OF ILLNESS INDEX; SMELL;

EID: 2342432256     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.11.1995     Document Type: Article

References (46)

1. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82:239-259
2. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996; 16:4491-4500
3. Kovacs T, Cairns NJ, Lantos PL: Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 2001; 12:285-288
4. Koss E, Weiffenbach JM, Haxby JV, Friedland RP: Olfactory detection and recognition in Alzheimer's disease (letter). Lancet 1987; 1:622
5. Doty RL, Reyes PF, Greogor T: Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987; 18:597-600
6. Serby M, Larson P, Kalstein D: The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991; 148:357-360
7. Mesholam RI, Moberg PJ, Mahr RN, Doty RL: Olfaction in neurodegenerative disease. Arch Neurol 1998; 55:84-90
8. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR: Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 1990; 11:465-469
9. Nordin S, Almkvist O, Berglund B, Wahlund LO: Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Arch Neurol 1997; 54:993-998
10. McCaffrey RJ, Duff K, Solomon GS: Olfactory dysfunction discriminates probable Alzheimer's dementia from major depression a cross validation and extension. J Neuropsychiatry Clin Neurosci 2000; 12:29-33
11. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000; 157:1399-1405
12. Bacon AW, Bondi MW, Salmon DP, Murphy C: Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann NY Acad Sci 1998; 855:723-731
13. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB: Impaired olfaction as a marker for cognitive decline, interaction with apolipoprotein E ε4 status. Neurology 1999; 53:1480-1487
14. Kareken DA, Doty RL, Mosnik D, Chen SH, Farlow MR, Hutchins GD: Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. Neuropsychology 2001; 15:18-29
15. Wetter S, Murphy C: Individuals with Down's syndrome demonstrate abnormal olfactory event-related potentials. Clin Neurophysiol 1999; 110:1563-1569
16. Wetter S, Murphy C: Apolipoprotein E ε4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiol Aging 2001; 22:439-447
17. Sakuma K, Nakashima K, Takahashi K: Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients Psychiatry Clin Neurosci 1996; 50:35-40
18. Hawkes CH, Shepard BC: Olfactory evoked responses and identification tests in neurological disease. Ann NY Acad Sci 1998; 855:608-615
19. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thai L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-1992
20. Herholz K: FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 1995; 9:6-16
21. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
22. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165
23. Erzigkeit H: The SKT - a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers, in Diagnosis and Treatment of Senile Dementia. Edited by Bergener M, Reisberg B. New York, Springer-Verlag, 1989, pp 164-174
24. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139:1136-1139
25. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
27. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Berejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmenn A, Scheinberg P: Vascular dementia, diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260
28. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G: "Sniffin' Sticks": olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory thresholds. Chem Senses 1997; 22:39-52
29. Kobal G, Klimek L, Wolfensberger M, Gudziol H, Temmel A, Owen CM, Seeber H, Pauli E, Hummel T: Multicenter investigation of 1036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and odor thresholds. Eur Arch Otorhinolaryngol 2000; 257:205-211
30. Kobal G: Pain related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 1985; 22:151-163
31. Kobal G, Hummel C: Cerebral chemosensory evoked potentials of the human nasal mucosa elicited by chemical stimulation. Electroencephalogr Clin Neurophysiol 1988; 71:241-250
32. Hummel T, Kobal G: Olfactory event-related potentials, in Methods in Chemosensory Research. Edited by Simon SA, Nicolelis MAL. Washington, DC, CRC Press, 2002, pp 129-464
33. Kobal G, Hummel T: Olfactory and intranasal trigeminal event-related potentials in anosmic patients. Laryngoscope 1998; 108:1033-1035
34. Thürauf N, Hummel T, Kettenmann B, Kobal G: Nociceptive and reflexive responses recorded from the human nasal mucosa. Brain Res 1993; 629:293-299
35. Evans WJ, Kobal G, Lorig T, Prah JD: Suggestions for collection and reporting of chemosensory (olfactory) event-related potentials. Chem Senses 1993; 18:751-756
36. Barz S, Hummel T, Pauli E, Majer M, Lang CJG, Kobal G: Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 1997; 49:1424-1431
37. Kettenmann B, Hummel C, Stefan H, Kobal G: Multiple olfactory activity in the human neocortex identified by magnetic source imaging. Chem Senses 1997; 22:493-502
38. 2-stimulation of nasal mucosa: a magnetoencephelographic study in man. Electroencephalogr Clin Neurophysiol 1986; 64:347-349
39. Buchsbaum MS, Kesslack JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Arch Gen Psychiatry 1991; 48:840-847
40. Schiffmann SS: Taste and smell losses in normal aging and diseases. JAMA 1997; 278:1357-1362
41. Hummel T, Barz S, Pauli E, Kobal G: Chemosensory event-related potentials change with age. Electroencephalogr Clin Neurophysiol 1998; 108:208-217
42. Morgan CD, Covington JW, Geisler MW, Polich J, Murphy C: Olfactory event-related potentials: older males demonstrate the greatest deficits. Electroencephalogr Clin Neurophysiol 1997; 104:351-358
43. Pause B, Krauel K: Chemosensory event-related potentials (CSERP) as a key to the psychology of odors. Int J Psychophysiol 2000; 36.105-122
44. Sobel N, Thomason ME, Stappen I, Tanner CM, Tetrud JW, Bower JM, Sullivan EV, Gabrieli JDE: An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad Sci USA 2001; 98:4154-4159
45. Jagust W: Untangling vascular dementia Lancet 2001; 358:2097-2098
46. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD: Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001; 70:739-743